Behavioral observations, heart rate and cortisol monitoring in horses following multiple oral administrations of a cannabidiol containing paste (part 2/2).
Abstract: As a remedy against stress and anxiety, cannabidiol (CBD) products are of increasing interest in veterinary medicine. Limited data is available describing the actual effectiveness of CBD in horses. The aim of this study (part 2 of 2) was to analyze stress parameters via behavioral observation, heart rate monitoring and assessment of blood and saliva cortisol levels in healthy horses treated repeatedly with a CBD containing paste. Twelve horses were randomly assigned to a treatment or a control group. Two pastes were orally administered in a double-blinded study design, one paste containing CBD and one paste without active ingredient. Both pastes were administered twice daily over 15 days (dose: 3 mg CBD/kg). Behavioral observations were conducted daily using a sedation score and a rating of facial expressions, based on the previously described facial sedation scale for horses (FaceSed) and the Horse Grimace Scale. Blood and saliva samples were obtained regularly to determine cortisol levels throughout the study. Cortisol levels were analyzed by means of liquid chromatography/tandem mass spectrometry (LC/MS/MS). Behavioral observations and cortisol levels were compared between groups. Prior to paste administration, a novel object test was performed and the horses' reaction to loading on a trailer was recorded. Both tests were repeated after 13 days of paste application. Movement patterns such as different gaits during the novel object test were evaluated and an ethogram was designed to assess exhibited behavioral traits. Cardiac beat-to-beat (R-R) intervals were recorded throughout and evaluated using heart rate (HR) and heart rate variability (HRV) parameters. Blood and saliva samples for cortisol analysis were taken before and after the tests. Daily behavioral observations and cortisol levels did not differ between the treatment and the control group. Similarly, analysis of movement patterns, HR, HRV and cortisol levels during the novel object test and trailer test did not identify significant differences between the groups. Regularly administered oral CBD (3 mg/kg BID over 15 days) had no statistically significant effect on behavioral observations, cortisol levels, HR and HRV in horses. Further research is required to establish adequate doses and indications for the use of CBD in horses.
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
This study investigates the effectiveness of cannabidiol (CBD) for managing stress in horses, using behavior observation, heart rate monitoring, and cortisol level analysis. Using a randomized, double-blind setup, the experiment compared the results of 12 horses given a CBD past over 15 days against those given a placebo, finding no significant difference in behavior, heart rate or cortisol levels.
Methodology
The researchers took 12 horses and divided them equally into a control group and a treatment group. These groups received different pastes — the treatment group ingested a paste containing 3 mg/kg of CBD, while the control group received a paste without any active ingredient.
The pastes were administered orally twice a day over a course of 15 days.
Behavioral observation was performed daily, using a sedation score and studying facial expressions from the FaceSed and Horse Grimace Scale. These scales allowed the researchers to rate the level of sedation and painful grimacing in horses.
Cortisol and Heart Rates Monitoring
The researchers collected blood and saliva samples from the horses regularly to measure their cortisol levels. Cortisol is a hormone that is usually elevated during stress.
Liquid chromatography/tandem mass spectrometry (LC/MS/MS) was used to analyze cortisol levels.
The heart rates of the horses were also continually monitored, with the team looking specifically at R-R intervals for heart rate variability.
Stress Evaluation
Before starting CBD administration, horses underwent a novel object test and their reactions to being loaded onto a trailer were recorded.
After 13 days of the treatment, these tests were repeated.
Results and Conclusion
The researchers did not find any significant differences in the horses’ daily behavioral observations or cortisol levels between the CBD-treated horses and the controls.
There was no significant change in movement patterns, heart rate, heart rate variability, and cortisol levels during the novel object test and trailer loading test between the groups.
Overall, the study found that the administration of CBD paste (3 mg/kg BID over 15 days) did not have a statistically significant effect on behavior, cortisol levels, or heart rate in horses.
More research is called for to establish appropriate doses and indications for the use of CBD in horses.
Cite This Article
APA
Eichler F, Ehrle A, Machnik M, Jensen KC, Wagner S, Baudisch N, Bolk J, Pötzsch M, Thevis M, Bäumer W, Lischer C, Wiegard M.
(2024).
Behavioral observations, heart rate and cortisol monitoring in horses following multiple oral administrations of a cannabidiol containing paste (part 2/2).
Front Vet Sci, 10, 1305873.
https://doi.org/10.3389/fvets.2023.1305873
Equine Clinic, Veterinary Hospital Freie Universität Berlin, School of Veterinary Medicine, Freie Universität Berlin, Berlin, Germany.
Ehrle, Anna
Equine Clinic, Veterinary Hospital Freie Universität Berlin, School of Veterinary Medicine, Freie Universität Berlin, Berlin, Germany.
Machnik, Marc
Center for Preventive Doping Research, Institute of Biochemistry, German Sport University Cologne, Cologne, Germany.
Jensen, Katharina Charlotte
Institute of Veterinary Epidemiology and Biostatistics, School of Veterinary Medicine, Freie Universität Berlin, Berlin, Germany.
Wagner, Sabrina
Center for Preventive Doping Research, Institute of Biochemistry, German Sport University Cologne, Cologne, Germany.
Baudisch, Natalie
Equine Clinic, Veterinary Hospital Freie Universität Berlin, School of Veterinary Medicine, Freie Universität Berlin, Berlin, Germany.
Bolk, Julia
Equine Clinic, Veterinary Hospital Freie Universität Berlin, School of Veterinary Medicine, Freie Universität Berlin, Berlin, Germany.
Pötzsch, Magdalena
Equine Clinic, Veterinary Hospital Freie Universität Berlin, School of Veterinary Medicine, Freie Universität Berlin, Berlin, Germany.
Thevis, Mario
Center for Preventive Doping Research, Institute of Biochemistry, German Sport University Cologne, Cologne, Germany.
Bäumer, Wolfgang
Institute of Pharmacology and Toxicology, School of Veterinary Medicine, Freie Universität Berlin, Berlin, Germany.
Lischer, Christoph
Equine Clinic, Veterinary Hospital Freie Universität Berlin, School of Veterinary Medicine, Freie Universität Berlin, Berlin, Germany.
Wiegard, Mechthild
Institute of Animal Welfare, Animal Behavior and Laboratory Animal Science, School of Veterinary Medicine, Freie Universität Berlin, Berlin, Germany.
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
This article includes 102 references
Fogaça MV, Campos AC, Coelho LD, Duman RS, Guimarães FS. The anxiolytic effects of cannabidiol in chronically stressed mice are mediated by the endocannabinoid system: role of neurogenesis and dendritic remodeling.. Neuropharmacology (2018) 135:22–33.
Moltke J, Hindocha C. Reasons for cannabidiol use: a cross-sectional study of CBD users, focusing on self-perceived stress, anxiety, and sleep problems.. J Cannabis Res (2021) 3:5.
Gamble L-J, Boesch JM, Frye CW, Schwark WS, Mann S, Wolfe L. Pharmacokinetics, safety, and clinical efficacy of Cannabidiol treatment in osteoarthritic dogs.. Front Vet Sci (2018) 5:165.
Draeger AL, Thomas EP, Jones KA, Davis AJ, Porr CS. The effects of pelleted cannabidiol supplementation on heart rate and reaction scores in horses.. J Vet Behav (2021) 46:97–100.
Golombek P, Müller M, Barthlott I, Sproll C, Lachenmeier DW. Conversion of Cannabidiol (CBD) into psychotropic cannabinoids including tetrahydrocannabinol (THC): a controversy in the scientific literature.. Toxics (2020) 8:8.
Casajuana Köguel C, López-Pelayo H, Balcells-Olivero MM, Colom J, Gual A. Constituyentes psicoactivos del cannabis y sus implicaciones clínicas: una revisión sistemática.. Adicciones (2018) 30:140–51.
Gomes FV, Resstel LB, Guimarães FS. The anxiolytic-like effects of cannabidiol injected into the bed nucleus of the stria terminalis are mediated by 5-HT1A receptors.. Psychopharmacology (2011) 213:465–73.
Crippa JA, Derenusson GN, Ferrari TB, Wichert-Ana L, Duran FL, Martin-Santos R. Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report.. J Psychopharmacol (Oxford, England) (2011) 25:121–30.
Resstel LB, Joca SR, Moreira FA, Corrêa FM, Guimarães FS. Effects of cannabidiol and diazepam on behavioral and cardiovascular responses induced by contextual conditioned fear in rats.. Behav Brain Res (2006) 172:294–8.
Morris EM, Kitts-Morgan SE, Spangler DM, Gebert J, Vanzant ES, McLeod KR. Feeding Cannabidiol (CBD)-containing treats did not affect canine daily voluntary activity.. Front Vet Sci (2021) 8:645667.
Shallcross J, Hámor P, Bechard AR, Romano M, Knackstedt L, Schwendt M. The divergent effects of CDPPB and Cannabidiol on fear extinction and anxiety in a predator scent stress model of PTSD in rats.. Front Behav Neurosci (2019) 13:91.
Fusar-Poli P, Crippa JA, Bhattacharyya S, Borgwardt SJ, Allen P, Martin-Santos R. Distinct effects of Δ9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing.. Arch Gen Psychiatry (2009) 66:95–105.
Williams NN, Ewell TR, Abbotts KS, Harms KJ, Woelfel KA, Dooley GP. Comparison of five Oral Cannabidiol preparations in adult humans: pharmacokinetics, body composition, and heart rate variability.. Pharmaceuticals (Basel) (2021) 14.
De Gregorio D, McLaughlin RJ, Posa L, Ochoa-Sanchez R, Enns J, Lopez-Canul M. Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain.. Pain (2019) 160:136–50.
Fogaça MV, Campos AC, Guimarães FS. Cannabidiol and 5-HT1A receptors. In: Neuropathology of drug addictions and substance misuse: Elsevier; (2016). 749–59.
Izzo AA, Borrelli F, Capasso R, Di Marzo V, Mechoulam R. Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb.. Trends Pharmacol Sci (2009) 30:515–27.
Campos AC, Moreira FA, Gomes FV, Del Bel EA, Guimarães FS. Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders.. Philos Trans R Soc Lond Ser B Biol Sci (2012) 367:3364–78.
Watanabe K, Kayano Y, Matsunaga T, Yamamoto I, Yoshimura H. Inhibition of anandamide amidase activity in mouse brain microsomes by cannabinoids.. Biol Pharm Bull (1996) 19:1109–11.
Riebe CJ, Pamplona FA, Kamprath K, Wotjak CT. Fear relief-toward a new conceptual frame work and what endocannabinoids gotta do with it.. Neuroscience (2012) 204:159–85.
McLaughlin RJ, Hill MN, Gorzalka BB. A critical role for prefrontocortical endocannabinoid signaling in the regulation of stress and emotional behavior.. Neurosci Biobehav Rev (2014) 42:116–31.
McPartland JM, Mac Donald C, Young M, Grant PS, Furkert DP, Glass M. Affinity and efficacy studies of Tetrahydrocannabinolic acid a at cannabinoid receptor types one and two.. Cannabis Cannabinoid Res (2017) 2:87–95.
de Petrocellis L, Ligresti A, Moriello AS, Allarà M, Bisogno T, Petrosino S. Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes.. Br J Pharmacol (2011) 163:1479–94.
Briyne N, De HD, Sandler I, Stiles E, Szymanski D, Moody S. Cannabis, Cannabidiol oils and tetrahydrocannabinol-what do veterinarians need to know?. Animals (Basel) (2021) 11.
De OAR, Gozalo-Marcilla M, Ringer SK, Schauvliege S, Fonseca MW, Esteves Trindade PH. Development and validation of the facial scale (face Sed) to evaluate sedation in horses.. PLoS One (2021) 16:e0251909.
De OAR, Gozalo-Marcilla M, Ringer SK, Schauvliege S, Fonseca MW, Trindade PH. Development, validation, and reliability of a sedation scale in horses (Equi Sed).. Front Vet Sci (2021) 8:611729.
Peeters M, Closson C, Beckers J-F, Vandenheede M. Rider and horse salivary cortisol levels during competition and impact on performance.. J Equine Vet (2013) 33:155–60.
Becker-Birck M, Schmidt A, Lasarzik J, Aurich J, Möstl E, Aurich C. Cortisol release and heart rate variability in sport horses participating in equestrian competitions.. J Vet Behav (2013) 8:87–94.
Tateo A, Padalino B, Boccaccio M, Maggiolino A, Centoducati P. Transport stress in horses: effects of two different distances.. J Vet Behav (2012) 7:33–42.
Santos Godoi TL, Villas-Boas JD, Almeida NA, Trigo PI, De AFQ, De MMA. Pharmacopuncture versus Acepromazine in stress responses of horses during road transport.. J Equine Vet (2014) 34:294–301.
Turner PL, Guay KA, Jones T, Cohen L, Elwonger F, van Geem R. 113 Cannabidiol supplementation and physiological response in transported horses.. J Anim Sci (2022) 100:33.
Draeger AL, Hoffman LK, Godwin PR, Davis AJ, Porr SA. Pharmacokinetics of a single feeding of pelleted cannabidiol in horses.. Steeplechase: Murray State University (2020).
Schwark WS, Wakshlag JJ. A one health perspective on comparative cannabidiol and cannabidiolic acid pharmacokinetics and biotransformation in humans and domestic animals.. Am J Vet Res (2023) 84:1–9.
Dalla Costa E, Bracci D, Dai F, Lebelt D, Minero M. Do different emotional states affect the horse grimace scale score? A pilot study.. J Equine Vet (2017) 54:114–7.
Kogan L, Schoenfeld-Tacher R, Hellyer P, Rishniw M. US Veterinarians' knowledge, experience, and perception regarding the use of Cannabidiol for canine medical conditions.. Front Vet Sci (2018) 5:338.
Kogan LR, Hellyer PW, Robinson NG. Consumers' perceptions of hemp products for animals.. J Am Holistic Vet Med Assoc JAHVMA (2016):42.
Boggs DL, Surti T, Gupta A, Gupta S, Niciu M, Pittman B. The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trial.. Psychopharmacology (2018) 235:1923–32.
Morris EM, Kitts-Morgan SE, Spangler DM, McLeod KR, Costa JH, Harmon DL. The impact of feeding Cannabidiol (CBD) containing treats on canine response to a noise-induced fear response test.. Front Vet Sci (2020) 7:569565.
Hunt AB, Flint HE, Logan DW, King T. A single dose of cannabidiol (CBD) positively influences measures of stress in dogs during separation and car travel.. Front Vet Sci (2023) 10:1112604.
Appiah-Kusi E, Petros N, Wilson R, Colizzi M, Bossong MG, Valmaggia L. Effects of short-term cannabidiol treatment on response to social stress in subjects at clinical high risk of developing psychosis.. Psychopharmacology (2020) 237:1121–30.
Mongeau-Pérusse V, Rizkallah E, Morissette F, Brissette S, Bruneau J, Dubreucq S. Cannabidiol effect on anxiety symptoms and stress response in individuals with cocaine use disorder: exploratory results from a randomized controlled trial.. J Addict Med (2022) 16:521–6.